Efficacy of intra-arterial contrast-enhanced ultrasonography during transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma

Table 2 Adverse events in 32 patients after 39 transarterial chemoembolization with drug-eluting beads procedures

Adverse event	Grade 1-24	Grade 3-44
Fever ≥ 37.5 °C	19 (48.7)	0
Abdominal pain	3 (7.7)	0
Nausea and/or vomiting	0	0
Catheterization-site bleeding1	0	0
Transient renal insufficiency	0	0
Groin hematoma2	0	0
Liver decompensation3	0	0
Hepatic abscess	0	0
Intratumor bleeding	0	0

Data are given as n (%).

¹Controlled with local compressive medication;

²Both self-limiting and resolved within 2 wk of the procedure;

³Mild ascites treated successfully with oral aldosterone antagonists;

⁴According to the CTCAE, version 4.0 (v4.03). CTCAE: Common Terminology Criteria for Adverse Events.